Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bioservo applies for delisting from Nasdaq First North

At the extraordinary general meeting held in Bioservo Technologies (BIOS) (the “Company") on December 14, 2023, it was decided that the Company would enter into voluntary liquidation in accordance with Chapter 25, Section 3 of the Companies Act, effective from the time of the Companies Registration Office's appointment of a liquidator. Against this background, the Company has, on behalf of the Board of Directors, applied for delisting of the Company's shares from Nasdaq First North Growth Market. The last day of trading in the Company's shares will be announced through a separate press

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 14 December 2023 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 14 December 2023 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)

WPTG expands capacity in its Global Delivery Centers to target thirty percent growth in revenue and profit

White Pearl Technology Group (WPTG) is launching a strategic plan to significantly expand its talent infrastructure across Global Delivery Centers (GDC), targeting a thirty percent increase in revenue and profit growth in these centers by 2024. The impact of this initiative is estimated to be about fiften percent on company group level, in the comming year.WPTG operates ten GDC´s in countries like South Africa, Egypt, Zimbabwe, Ethiopia, and India. Through these GDC´s, WPTG clients gain 24x7-access to highly skilled teams with specialised competencies, including SAP S/4HANA migration

Norwegian Competition Authority approves Nordea’s proposed acquisition of Danske Bank’s personal customer business

Nordea entered into an agreement  with Danske Bank to acquire its Norwegian personal customer and private banking business and associated asset management portfolios on 19 July 2023. Today the Norwegian Competition Authority has announced its approval of the acquisition. The proposed acquisition will strengthen Nordea’s market position in Norway among household customers. - We are pleased with the authority’s thorough review and clear conclusion.

Vestas wins 186 MW project in Finland

News release from Vestas Northern and Central EuropeHamburg, 15 December 2023 Vestas has received a firm order from Ilmatar, Nordic energy company and Independent Power Producer (IPP), for the Pahkakoski project in the municipality Ii, located 60km from the city of Oulu, Finland.    The order consists of 30 V162-6.2 MW wind turbines and includes supply, delivery, and commissioning of the turbines. Upon completion, Vestas will service the turbines under a 30-years Active Output Management 5000 (AOM 5000) service agreement designed to ensure optimised performance of the assets. “

BLAST Premier and Magnum partner for World Final Abu Dhabi 2023

World-renowned ice cream brand Magnum has partnered with BLAST Premier for the upcoming World Final (13-17 December) in Abu Dhabi - where the world’s eight best Counter-Strike teams will battle it out for an eye-watering $1 million prize pool.  The event partnership between BLAST Premier and the Unilever-owned brand Magnum will see the ice cream brand integrated across the BLAST Premier World Final broadcast online and in-person in the Etihad Arena, with physical and digital branding as well as dedicated broadcast segments.  On top of broadcast integration, Magnum will feature across

STENA LINE TO LAUNCH NEW FREIGHT ROUTE FROM DUBLIN TO BIRKENHEAD (LIVERPOOL)

Stena Line has confirmed plans to launch a new freight service between Dublin and Birkenhead (Liverpool) starting mid-February 2024.The new service will initially operate with one ship departing Dublin early in the morning and making the return journey from Birkenhead in the evening. Stena Line already operates from Dublin Port and Birkenhead, and this new service will complement the existing routes from Dublin to Holyhead and Belfast to Liverpool. The company is currently assessing ship deployment options for the service. Niclas Mårtensson, CEO, Stena Line said: “The launch of our

Lancaster girl heads to London horse show championship

A little girl from Lancaster and her Welsh pony will be the oldest pony and the youngest rider competing at a prestigious international horse show final this month. They are making the six-hour trip to contest a championship at the London International Horse Show at ExCel this weekend.Grace Speak, aged 4, and her Welsh Section B pony Mountain Gale, aged 30, have qualified to contest the finals of the Agria Senior Showing and Dressage League (SSADL) on Saturday (16th December). The class forms part of the programme at the London International Horse Show, at which many of the world’s best

Webstep ASA: Notice of extraordinary general meeting

Oslo, 15 December 2023: An extraordinary general meeting of Webstep ASA (the “Company”) will be held on Friday 5 January 2024 at 10:00 hours (CET).The notice and agenda for the extraordinary general meeting is attached hereto and is also sent to the Company's shareholders.The extraordinary general meeting will be held as an electronic meeting via Orgbrain. Information and guidelines for electronic participation will be made available at the Company's webpage and will be sent to the shareholders who wish to attend the general meeting.  Further, the notice and its appendices will be made

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 224 - 15 DECEMBER 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 186/23 and 187/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Update on Progress in Katalysen's Venture Targeter

Katalysen’s portfolio company Venture Targeter AB ("Venture Targeter") recently announced its inaugural investment into biotech company QuTEM (formerly Vironova BioAnalytics). Readers will find a more detailed presentation (PDF) attached with this press release.Venture Targeter, established by Katalysen Ventures AB (publ) (“Katalysen”), is dedicated to identifying, structuring, and executing special situation investments in collaboration with co-investors and industry experts. Specializing in distressed assets and the turnaround of companies to maximize value extraction, Venture Targeter

Omada Selects DecideAct Software to Streamline Strategy Execution

DecideAct has signed a contract with Omada, a global leader in Identity Governance and Administration (IGA) for blue-chip clients in Europe and the US. Omada will use DecideAct's digital platform to manage its own strategic initiatives.Identity Governance and Administration have become a cornerstone of solid IT Security, allowing organizations to implement processes for controlling, managing, and auditing access to data, which is an important prerequisite to reducing security risk. Omada's identity governance solution helps organizations around the world manage and govern identities

Cereno Scientific’s innovative drug candidate CS585 featured as one of the future antiplatelet strategies in the top-tier Journal of Thrombosis and Haemostasis

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that a review article titled “Antiplatelet strategies: past, present, and future” highlighted the company's innovative drug candidate CS585 as a promising future strategy in reducing platelet activity. The review article published in the prestigious Journal of Thrombosis and Haemostasis 20th anniversary issue in December further states that antiplatelet therapy plays a critical role in the prevention and treatment of major cardiovascular

BioStock: Medivir clears key hurdles ahead of phase IIb

While currently conducting a rights issue, Medivir has rapidly progressed the development of the drug candidate fostrox for the treatment of liver cancer. Firstly, they have completed the development of an updated formulation of fostrox suitable for commercial manufacture. Additionally, they have secured agreements for the manufacturing of fostrox GMP substance for clinical trials. The goal is to expedite necessary activities to initiate a pivotal phase IIb study in 2024, with the aim of accelerated approval in 2027.Read the article at biostock.se: https://www.biostock.se/en/2023/12/

Integrum’s MDR certification is completed for the OPRA[TM] Implant System

Mölndal, Sweden – December 15, 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has received its final MDR certification, thus finalizing the review process of the company’s products under the new EU medical device regulatory (MDR) framework. The company’s OPRA[TM] Implant System product portfolio has thereby been granted MDR certification and may be freely distributed within the EU for treatment in individuals living with disabilities because of limb loss.Integrum received its MDR certification (Notified Body BSI \2797\) for the last

Historical numbers for 2022 and 2023 recalculated in relation to the new divisional structure

As previously communicated, AFRY X ceased to exist as a division on October 1, 2023 and the existing business units were integrated into the Industrial & Digital Solutions, Infrastructure and Management Consulting divisions. As a consequence, AFRY's reporting structure changed from six to five divisions and below are the restated historical numbers for 2022 and the first three quarters of 2023.Net sales, SEK Q1 Q2 Q3 Q4 FY Q1 Q2 Q3million 2022 2022 2022 2022 2022 2023 2023 2023Infrastructure 2,276 2,305 1,966

AFRY to support Nordic Paper’s strategic investments for sustainable kraft paper production

Nordic Paper, a leading specialty paper producer with its base in Scandinavia, has selected AFRY as its engineering and project management partner for the strategic investment projects at its Bäckhammar mill in Sweden. The projects include a new wood room and a new electrostatic filter.Nordic Paper has decided to invest approximately MSEK 850 to enhance the sustainability performance and competitiveness of the Bäckhammar mill, which produces kraft paper for various applications. An important component of the investment is a new wood room providing for both strategic flexibility in raw

Partial results from Dicot's phase 1 trial to be presented early next year

Press Release: Uppsala, December 15, 2023. Yesterday, the potency drug developer Dicot concluded the clinical part of the SAD, earlier than initially planned. Consequently, the company will be able to report these results already in the January-to-February transition. Results from the second and final part of the phase 1 trial are expected to be communicated in the second quarter of next year, as previously announced.Dicot's phase 1 trial of the potency drug candidate LIB-01 is placebo-controlled and double-blinded, with the primary objective of investigating the safety profile in humans.

Sensys Gatso receives an order from Croatia worth SEK 13.5 million

Sensys Gatso Group, a global leader in traffic safety solutions, has received a purchase order from its local partner in Croatia, Meditronik, for the delivery and maintenance of traffic-safety cameras to the Croatian MOI. The purchase order to Sensys Gatso has a value of EUR 1.2 million, corresponding to SEK 13.5 million.Deliveries of the systems, based on the T-series platform, will take place during the year 2023 - 2026 and the service agreement is for 6 years. The systems will be used for enforcing speed, mainly on state and municipal roads.   “Sensys Gatso and its partner Meditronik

Pricer initiates a cost-savings program which leads to savings of approximately 50 MSEK for long-term competitiveness and profitable growth

Pricer AB ("Pricer" or the "Company") has decided to initiate a cost-savings program, with expected savings of approximately 50 MSEK per year, and plans a restructuring of the organization. The restructuring is estimated to cost approximately 18 MSEK which will be charged to the fourth quarter 2023.During the process, the intangible assets of the company have also been evaluated. A write-down of capitalized development projects of approximately 14 MSEK will thereby be charged to the fourth quarter of 2023. The one-off costs do not affect the covenants in the company's loan agreement. Full

edyoutec signs publisher agreement with MAF for the mobile game King Royale

Press release on December 15, 2023 edyoutec announces that it has signed a publishing agreement with MAF for the mobile game King Royale. This initially means that Edyoutec, together with MAF, begins a test period with the aim of increasing the monetization of the game. MAF has the opportunity to expose King Royale to its user base of 50 million monthly users.After a series of successful game updates, King Royale has achieved stronger KPIs and is ready to focus on monetization to further strengthen its presence in the gaming market. The agreement means that MAF markets and evaluates

COVID-19 infection alters gene transcription of olfactory mucosal cells in Alzheimer's disease

A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer's disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes. The study was conducted at the University of Eastern Finland in collaboration with the University of Helsinki and published in Journal of Neuroinflammation. The study was prompted by concerns about the impact of COVID-19 on individuals with pre-existing conditions such as Alzheimer’s disease (AD). Olfactory dysfunction, characterized by an impaired sense of

MyFirstApp: Set to Launch Evolear Beta as Planned

Stockholm, Sweden – 2024-12-15MyFirstApp Sweden AB, aspiring to be a leader in AI-based educational technology, proudly announces that they are in the final stages of development for the beta launch of Evolear. This innovative platform, set to launch before Christmas, offers a unique and personalized learning experience to children worldwide. Evolear – A new era in Ed-TechEvolear is a groundbreaking AI-based platform, designed to enhance learning through individualized pedagogy. It dynamically adapts to each student's abilities and progress, transforming the traditional educational

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseDecember 15, 2023, at 9.30 am EETRepurchase of Outokumpu’s own shares On December 14, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |82,890 |4.4611

There are no items matching the current filter
There are no more items matching the current filter
Back to top